Hu Jie
Hu Jie — Chief Physician — Neurosurgery — Huashan Hospital Affiliated to Fudan University
Specialties
Diagnosis and treatment of epilepsy, Parkinson's disease, dystonia, glossopharyngeal or trigeminal neuralgia, hemifacial spasm, Meige syndrome, tic disorders, spasmodic torticollis, pain or increased muscle tone after spinal cord injury, postoperative spinal pain, pain after brachial plexus injury, residual/phantom limb pain, central pain (thalamic pain, post-stroke pain, etc.), cancer pain, spastic limb pain, increased muscle tone after cerebral hemorrhage or cerebral infarction, various cranial tumors (meningioma, glioma, trigeminal schwannoma, acoustic neuroma, cavernous hemangioma, etc.), intraspinal and extraspinal schwannomas, intramedullary spinal cord tumors, and other complex neurosurgical disorders.
Education
PhD in Neurosurgery, Shanghai Medical College, Fudan University Bachelor in Clinical Medicine, Shanghai Medical University
Professional Experience
Chief Physician, Professor, Doctoral Supervisor, and Doctor of Medicine at the Department of Neurosurgery, Huashan Hospital Affiliated to Fudan University; postdoctoral fellow in the United States. One of the main founders and the first head of the functional neurosurgery subspecialty team at Huashan Hospital. Since 1993, has been engaged in neurosurgery clinical work at Huashan Hospital, accumulating extensive clinical experience. Skilled in surgical treatment of drug-resistant epilepsy, Parkinson's disease, dystonia, glossopharyngeal or trigeminal neuralgia, hemifacial spasm, Meige syndrome, Tourette's syndrome, spasmodic torticollis, post-spinal cord injury pain, post-spinal surgery pain, post-brachial plexus injury pain, residual/phantom limb pain, central pain (thalamic pain, post-stroke pain, etc.), cancer pain, spastic limb pain, various brain tumors (meningioma, glioma, trigeminal schwannoma, acoustic neuroma, cavernous hemangioma, etc.), intraspinal and extraspinal nerve sheath tumors, intramedullary spinal tumors, and other complex neurosurgical conditions. Performs nearly 1,000 surgeries annually, with a cumulative total of nearly 20,000 surgeries to date, achieving widely praised therapeutic outcomes. Was among the earliest in China to perform lateral ventricle drug infusion system implantation for drug-resistant chronic pain, achieving good results and providing new treatment options for patients with chronic pain and spastic conditions; was also the earliest to carry out dorsal root entry zone (DREZ) lesioning surgery for drug-resistant chronic pain in East China, and is currently one of the domestic experts with the largest number of cases and best outcomes for this procedure; also an early adopter in China of stereotactic EEG (SEEG) and cerebral hemisphere disconnection surgeries in epilepsy surgery, with extensive experience in surgical removal and functional protection of epileptogenic foci in motor and language functional areas, guiding students to win multiple first prizes in nationwide epilepsy surgery case competitions. Since 2013, has strongly promoted the use of glue adhesion vascular transposition technique in microvascular decompression surgery for trigeminal neuralgia and hemifacial spasm in China, reducing recurrence rates and improving surgical outcomes. Visiting scholar at Prince of Wales Hospital, The Chinese University of Hong Kong from September 1998 to September 1999. Postdoctoral fellow at the University of Southern California (USC) from July 2008 to July 2009. Has participated in research projects funded by the National Natural Science Foundation, Ministry of Education, Ministry of Health, and Shanghai Municipal Government, among others. Review expert for journals including Journal of Clinical Neuroscience, World Neurosurgery; editorial board member for Frontiers in Neurology, Stereotactic and Functional Neurosurgery Journal.
Professional Roles
Chinese Medical Association Member Current or Former Positions: Member of the Functional Neurosurgery Group, Neurosurgery Branch of the Chinese Medical Association; Deputy Chair of the Peripheral Nerve Professional Committee, Chinese Medical Doctor Association; Vice President of the Shanghai Epilepsy Association; Deputy Leader of the Stereotactic and Functional Neurosurgery Group, Shanghai Neurosurgery Society; Deputy Chair of the Neuroregulation and Functional Rehabilitation Special Committee, China Human Health Technology Promotion Association; Deputy Leader of the Cranial Nerve Diseases Group, Peripheral Nerve Professional Committee, Chinese Medical Doctor Association; Director of the Chinese Epilepsy Association; Member of the Neuroregulation Special Committee, Chinese Epilepsy Association; Member of the Neuroregulation Professional Committee, Chinese Medical Doctor Association; Member of the Committee, World Cranial Nerve Disease Surgical Physicians Alliance; Member of the Functional Neurosurgery Special Committee, World Chinese Physicians Association; Member of the Stereoelectroencephalography and Brain Localization Professional Committee, Chinese Epilepsy Association; Member of the Innovation and Translation Professional Committee, Chinese Epilepsy Association; Director, China Neuroregulation Alliance; Member of the Neuroregulation and Artificial Intelligence Group, Neurorestoratology Professional Committee, Chinese Medical Doctor Association; Member of the Neurodegeneration and Rehabilitation Group, Neurorestoratology Professional Committee, Chinese Medical Doctor Association; Member of the Epilepsy and Electroencephalography Group, Shanghai Medical Association, Department of Neurology; Deputy Director, Neuromonitoring Professional Committee, Shanghai Electrophysiology and Rehabilitation Technology Innovation Strategic Alliance; Member of the Psychiatric Disorders Group, Neuroregulation Professional Committee, Chinese Medical Doctor Association; Member of the Preoperative Evaluation and Surgical Techniques Special Committee for Qi-fu Tan Epilepsy Surgery, Chinese Epilepsy Association